Access brought to you by: LOCKSS

Cardiology Clinical Trials

Losartan Reduces Aortic Dilatation Rate in Adults with Marfan Syndrome
Omecamtiv Mecarbil: Phase 2 Study Shows No Improvement in Dyspnea AHF But Trend for Further Exploration
Saxagliptin and Alogliptin Noninferior for CV Ischemic Events in Patients at High Risk with T2DM and Coronary Disease
Postrevascularization Survival among South Asians Admitted with an Acute Coronary Syndrome
No Improvement with CRT in Patients with HF and QRS <130 msec
Initial Data from CCS Registry Shows Low Complication Rate in Interventional Cases
Cangrelor Reduces Thrombotic Events among Patients Undergoing PCI
When to Consider Leptospirosis in Unexplained Myocarditis
Catheter-Based Renal Artery Denervation – Sustained Blood Pressure Lowering with Reassuring Safety at 3 Years
CKD, CVD, and Lipids: Insights from the SHARP Trial

Pages